News for '-nuvama-institutional-equities'

ITC stock downgraded after excise duty hike

ITC stock downgraded after excise duty hike

Rediff.com3 Jan 2026

Analysts have sharply reduced cigarette maker ITC's earning estimates for the next two years, fearing a significant dent in the company's profitability and margins. This is owing to a steep hike in excise duty on tobacco by the government.

MFs split on IT revival as outlook improves but uncertainties remain

MFs split on IT revival as outlook improves but uncertainties remain

Rediff.com24 Nov 2025

Fund managers are divided on the prospects for beaten-down information technology (IT) stocks, reflected in the wide variance in equity mutual funds' (MFs) sector exposure. An analysis by Nuvama Alternative & Quantitative Research shows that while six large fund houses were overweight the sector relative to its weight in the Nifty 200 index, five were underweight as of October 2025. UTI MF had the highest exposure at 17.8 per cent, while SBI MF sat at the bottom with 5 per cent.

At Rs 1.45 trillion, Tata Motors sheds 40 pc of pre-merger valuation

At Rs 1.45 trillion, Tata Motors sheds 40 pc of pre-merger valuation

Rediff.com16 Oct 2025

The passenger vehicle (PV) business of Tata Motors, which also includes the electric vehicle and Jaguar Land Rover businesses, post-demerger is now valued at Rs 1.45 trillion.

Competition may keep Colgate under pressure

Competition may keep Colgate under pressure

Rediff.com25 Oct 2025

Colgate-Palmolive India's September quarter (Q2FY26) performance has reinforced concerns among brokerages about the company's continued market challenges.

GST rates cut: Challenges FMCG companies are facing

GST rates cut: Challenges FMCG companies are facing

Rediff.com24 Sep 2025

With lower GST rates taking effect, fast-moving consumer goods players face challenges in setting reduced prices for their products in round figures, but expect the magical price points to be restored within two months.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

Analysts' thumbs-up for Maruti's first e-SUV

Analysts' thumbs-up for Maruti's first e-SUV

Rediff.com2 Sep 2025

Maruti Suzuki's e-Vitara marks its high-stakes EV debut with strong export ambitions, lifting its stock even as analysts caution over pricing and fierce competition.

India's top IT cos wrap up Q1 with single-digit topline growth

India's top IT cos wrap up Q1 with single-digit topline growth

Rediff.com28 Jul 2025

India's top IT services firms delivered single-digit revenue growth in April-June, capping off a mixed, somewhat-sobering quarter as macroeconomic instability and geopolitical tensions weighed on global tech demand and delayed client decisionmaking. Management commentary painted a mixed picture, caution prevailed, yet industry CEOs also emphasised cost optimisation, vendor consolidation, and opportunities in AI makeovers.

National interest is our top priority: JioStar

National interest is our top priority: JioStar

Rediff.com9 May 2025

Firmly committed to prioritise national interest over all other considerations: JioStar

Bangladesh Unrest Hits India's Medical Tourism

Bangladesh Unrest Hits India's Medical Tourism

Rediff.com12 Jun 2025

Revenues from Bangladeshi patients have declined by 30% to 35% in 2024-2025. Bangladesh typically accounts for 70% to 75% of all medical visas issued by India.

Lock-up on nearly Rs 1.2 trillion pre-IPO shares to lift in two months

Lock-up on nearly Rs 1.2 trillion pre-IPO shares to lift in two months

Rediff.com2 Dec 2024

Lock up on shares worth nearly Rs 1.2 trillion ($14 billion) belonging to 50 companies will end between now and January 31, said Nuvama Institutional Equities in a note. Most of the shares are held by promoters, strategic investors or pre-listing shareholders in companies that have gone public in recent weeks or months.

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Rediff.com26 Jan 2025

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.

How ITC plans to build a future-ready portfolio

How ITC plans to build a future-ready portfolio

Rediff.com6 May 2025

There remains a debate on who said this: "When the facts change, I change my mind. What do you do, Sir?" Was it the British economist John Maynard Keynes or the American economist Paul Samuelson. Irrespective of who said it, this sentiment appears to have found resonance in ITC's boardroom in recent years.

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Rediff.com23 Dec 2024

India's healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According to data, key contributors to the record fundraising included Sai Life Sciences (Rs 3,043 crore), IKS Health (Rs 2,498 crore), and Sagility India (Rs 2,107 crore).

Analysts maintain 'Buy' calls on ICICI Bank after Q3; see up to 32% upside

Analysts maintain 'Buy' calls on ICICI Bank after Q3; see up to 32% upside

Rediff.com28 Jan 2025

Defying the bearish sentiment in the markets on Monday, ICICI Bank's share price rose by 2 per cent, reaching an intraday high of Rs 1,234.4 per share on the BSE. With a 1.5 per cent gain at the close, the stock emerged as the top performer on both the BSE Sensex and the National Stock Exchange Nifty 50 indices.

Why brokerages have revised their target prices for DMart

Why brokerages have revised their target prices for DMart

Rediff.com14 Jan 2025

Brokerages on DMart Q3 results: Avenue Supermarts (DMart) shares slipped as much as 5.74 per cent to hit an intraday low of Rs 3,474 per share on Monday. However, the stock recovered slightly to close at Rs 3,507.95, down 4.82 per cent. Notably, the 52-week low for DMart shares is Rs 3,400. The downward movement in DMart's share price was triggered by the company's 2024-25 (FY25) October-December quarter (Q3) results, which missed Street expectations.

Auto revenue may hit high gear on rural push, launches

Auto revenue may hit high gear on rural push, launches

Rediff.com28 Jan 2025

Overall, volume growth is likely to be in the range of 3-8 per cent for two-wheelers and 5-7 per cent for passenger vehicles owing to healthy demand from urban and rural areas and pending order books.

HDFC Bank Q3 a 'strong' quarter despite just 2% profit growth: Analysts

HDFC Bank Q3 a 'strong' quarter despite just 2% profit growth: Analysts

Rediff.com24 Jan 2025

Analysts have largely maintained their positive outlook on HDFC Bank, as the private lender reported in-line results for the October-December quarter (Q3) of the current financial year (2024-25/FY25). They believe the results were 'strong' given the tough macro environment, and relative to peers.

Why did IndiGo share price fall 5% post Q1 2024-25 results?

Why did IndiGo share price fall 5% post Q1 2024-25 results?

Rediff.com31 Jul 2024

IndiGo share price today: IndiGo share price fell as much as 4.8 per cent to a low of Rs 4,275 per share on the BSE in Monday's intraday trade as investors booked profit in the stock post a its April-June quarter (Q1) results for financial year 2024-25 (FY25). The stock ended 1.36 per cent lower at Rs 4,430 as against a 23-points gain in the benchmark BSE Sensex. The selling also got exacerbated as the management commentary, post Q1FY25 results, highlighted that inflationary pressure could likely dent July-September (Q2FY25) performance.

FMCG cos to face volume pressure in Q4

FMCG cos to face volume pressure in Q4

Rediff.com12 Apr 2024

Fast-moving consumer goods (FMCG) companies anticipate sustained volume pressures in the January-March quarter (Q4) coupled with sluggish rural growth during the period. Brokerages estimate top-line growth to be in low single digits in the quarter. Also, the late onset of winter had an impact on demand for winter products which range from moisturisers to hot beverages.

Reliance back on growth path, multiple catalysts to drive performance

Reliance back on growth path, multiple catalysts to drive performance

Rediff.com19 Jan 2025

Reliance Industries Ltd, India's most valuable company, is back on a growth path after six months of challenges as it posted better than expected earnings in the December quarter, brokerages said.

Not Asian Paints, Berger and Indigo Paints may shine in H2FY25, says Nuvama

Not Asian Paints, Berger and Indigo Paints may shine in H2FY25, says Nuvama

Rediff.com19 Dec 2024

The paint sector is seeing heightened competition with the entry of deep-pocketed groups like Aditya Birla and JSW. However, some brokerages see an opportunity in select stocks.

Tata Motors may drive out of Sensex, Nifty

Tata Motors may drive out of Sensex, Nifty

Rediff.com14 Mar 2024

Tata Motors is likely to exit the S&P BSE Sensex and the Nifty50 indices once the demerger process of its commercial vehicle (CV) and passenger vehicle (PV) businesses is complete, analysts at Nuvama Institutional Equities said. They have compared the development with Reliance Industries (RIL) and Jio Financial Services, which got listed separately and eventually (in the next few days) got excluded from the domestic indices.

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

IT aims for the sky after Accenture's Q4 results

IT aims for the sky after Accenture's Q4 results

Rediff.com5 Oct 2024

Global firm Accenture's fourth quarter results prove that the worst is behind for the Indian information technology (IT) sector, said analysts on Friday (September 27). While the pace and the broadness of recovery is debatable, they said Accenture's results and revenue growth guidance for the next financial year (FY25) reduce downside risks for Indian IT companies.

Watch Out For These Car Launches!

Watch Out For These Car Launches!

Rediff.com12 Aug 2024

Mahindra is coming up with the Thar Roxx. MG Motor India announced a third electric vehicle Windsor. Hyundai and Kia are expected to introduce updated versions of the Alcazar and Carnival respectively.

Sizzling Suzlon may rake in more moolah

Sizzling Suzlon may rake in more moolah

Rediff.com24 Aug 2024

Once declared a dud stock, Suzlon has generated stellar returns for investors thus far this calendar year. On a year-to-date (YTD) basis, Suzlon's share price has doubled investor wealth by soaring 109.35 per cent on the bourses. By comparison, the benchmark BSE Sensex has gained just 11.2 per cent.

As steel stocks falter, a silver lining for investors

As steel stocks falter, a silver lining for investors

Rediff.com21 Aug 2024

Stocks of Indian steel companies are reeling from pricing pressure that is partly blamed on cheap imports. The stocks have declined up to 9 per cent on the NSE in one month, likely allowing investors an opportunity to use the correction to enter the pack as pricing pressure eases. "In steel or any other commodity, if prices or spreads are nearing their bottom, it can be an opportune time to invest in those stocks. In India, domestic fundamentals such as steel consumption remain robust, hence one can take fresh positions in these counters," said Amit Dixit, an analyst at ICICI Securities.

Sebi's proposed tweaks likely to lead to big churn in F&O stocks

Sebi's proposed tweaks likely to lead to big churn in F&O stocks

Rediff.com11 Jun 2024

The market regulator's newly proposed selection criteria for the over Rs 400-trillion-a-day futures and options (F&O) market could pave the way for the entry of popular stocks such as Life Insurance Corporation (LIC) of India, Jio Financial Services, Zomato, Paytm, DMart, and Adani Energy into the derivatives segment. The Indian derivatives market, which accounts for most of the trading volumes, could see big churn with over two dozen exits from the current list of 182 stocks due to an upward revision in the eligibility thresholds.

Emami has built itself through acquisition, but...

Emami has built itself through acquisition, but...

Rediff.com8 Oct 2024

Two young men jostle in a rickshaw as it clatters along a narrow, bustling lane of North Kolkata, each with a leg dangling over the side of the vehicle, a bulging sack of cosmetics nestled between them. The protagonists here are the founders of Emami - Radhe Shyam Agarwal and Radhe Shyam Goenka - childhood friends who gave up cushy corporate jobs to build a fast-moving consumer goods (FMCG) company. From a 200-square-foot rented space on Muktaram Babu Street in North Kolkata, brand Emami stepped into the competitive world of FMCG 50 years back, armed with just three products: Vanishing cream, talcum powder, and cold cream.

As steel stocks falter, a silver lining for investors

As steel stocks falter, a silver lining for investors

Rediff.com28 Aug 2024

Stocks of Indian steel companies are reeling from pricing pressure that is partly blamed on cheap imports. The stocks have declined up to 9 per cent on the NSE in one month, likely allowing investors an opportunity to use the correction to enter the pack as pricing pressure eases. "In steel or any other commodity, if prices or spreads are nearing their bottom, it can be an opportune time to invest in those stocks.

Subdued festival sales may reflect in Q3 retail numbers

Subdued festival sales may reflect in Q3 retail numbers

Rediff.com15 Jan 2024

Retail companies are expected to witness a tepid strong same-store sales growth (SSSG) expansion in the third quarter (October - December) of the current financial year (Q3FY24) on the back of subdued sales in the festival season. The third quarter of the financial year typically witnesses higher sales since it coincides with the festival season. This time around, weak customer sentiment has dragged down SSSG.

Street Signs: Nifty50 enters 'overbought' zone

Street Signs: Nifty50 enters 'overbought' zone

Rediff.com26 Dec 2023

Going 'long' is becoming an overcrowded trade on Dalal Street, and any negative trigger could lead to a sharp correction, warn experts. However, given the strong momentum, particularly in IT stocks, the downside could be protected in the immediate term. "With the Nifty50 surging to new life-time highs, the bulls remain in control. Further upsides are likely once the immediate resistance of 21,492 is taken out.

Adani Group aims to become leader in cement sector in 4 years

Adani Group aims to become leader in cement sector in 4 years

Rediff.com22 Jun 2024

Ambuja Cements' announcement that it would acquire Hyderabad-based Penna Cement Industries could be the Adani Group company's first step for wider inorganic expansion, according to analysts.

HDFC Bank Q4 performance and future outlook

HDFC Bank Q4 performance and future outlook

Rediff.com30 Apr 2024

HDFC Bank's January-March quarter result, which came in-line with expectations, failed to enthuse investors. The reason? The management's decision to abstain from providing any specific growth guidance, and analysts' expectations of an arduous road to recovery. Analysts believe the path to normalisation of several growth metrics is unlikely to be a straightforward one, and the road to balance sheet realignment may be long.

Brokerages bullish on ICICI Bank stock after Q4 results

Brokerages bullish on ICICI Bank stock after Q4 results

Rediff.com8 May 2024

An in-line ICICI Bank result for the quarter ended March 31, 2024, has led to analysts raising target price and earnings per share (EPS) forecast on the stock. ICICI Bank, they said, appeared least vulnerable to regulatory action on its digital offerings or for risk monitoring lapses.

Axis Bank re-rating to continue on steady NIMs, cheap valuation: Analysts

Axis Bank re-rating to continue on steady NIMs, cheap valuation: Analysts

Rediff.com3 May 2024

Re-rating of Axis Bank's stock may continue in the near-future, believe analysts, as the risk-reward on the stock remains favourable amid healthy financials. The bullish stance comes after the Mumbai-based lender delivered a strong outperformance in the March quarter of fiscal year 2023-24 (Q4FY24) on core pre-provision profit and net profit, with improving asset quality. Axis Bank's net interest margin (NIM) expanded, against expectations, even in a tough market.

Tractor stocks may have bumpy ride in near-term; stay selective: Analysts

Tractor stocks may have bumpy ride in near-term; stay selective: Analysts

Rediff.com8 Mar 2024

After a stellar run on the bourses that saw tractor stocks rise up to 52 per cent, analysts are turning cautious on the sector as muted demand trends may weigh in the near-term. Total volumes in the tractor segment for the last three quarters of the current financial year (9MFY24) have remained weak with VST Tillers, Escorts Kubota, and M&M seeing declines of 21 per cent, 5 per cent, and 3 per cent year-on-year (Y-o-Y), respectively, during the period, amid patchy rainfall, delayed crop harvest, and lower reservoir level. Across industry, total domestic sales volume so far in the current financial year (April '23 to January '24) has declined 5 per cent Y-o-Y, as per Tractor Manufacturers Association (TMA).

Mutual funds buy the dip in IT stocks; invest Rs 9,500 crore in 2023

Mutual funds buy the dip in IT stocks; invest Rs 9,500 crore in 2023

Rediff.com30 May 2023

Mutual funds are loading up on information technology (IT) stocks on improved valuations and low downside risk after a double-digit correction in top companies like Infosys and Wipro. IT stocks were MFs' top sectoral buys in April when they invested a net of Rs 2,100 crore. In the first four months of 2023, the net investments in IT amounted to Rs 9,500 crore, shows an analysis by ICICI Securities.

Market analysts expect 'quality, growth' stocks to make comeback in 2024

Market analysts expect 'quality, growth' stocks to make comeback in 2024

Rediff.com25 Jan 2024

Most market analysts are expecting the momentum to shift towards 'quality' and 'growth' stocks in 2024 after the outperformance of 'value' stocks over the past three years. 'Value' stocks are generally well-established companies with steady profits that are trading at a discount to what they are intrinsically worth. Companies in sectors such as commodities, industrials, commercial vehicles and public sector units (PSUs) fall in this bracket.